Some antipsychotics and adjunctive antidepressants may minimize the risk of suicide in patients with schizophrenia

Author：  

Publisher： Adis International

ISSN： 1172-0360

Source： Drugs & Therapy Perspectives, Vol.27, Iss.10, 2011-10, pp. : 15-18

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimize the benefits and minimize the adverse effects of antipsychotics in patients with acute schizophrenia

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 25, Iss. 10, 2009-10 ,pp. : 12-16

Adis International

Access to resources Recommend Favorite

Pharmacogenetics of Response to Antipsychotics in Patients with Schizophrenia

By Arranz Maria J.  

CNS Drugs, Vol. 25, Iss. 11, 2011-11 ,pp. : 933-969

Adis International

Access to resources Recommend Favorite

The total quantity of high-dose tricyclic antidepressants that can be obtained by patients at risk of suicide is a concern

By  

Reactions Weekly, Vol. 1, Iss. 1022, 2004-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Antidepressants found to reduce, not raise, suicide risk

By  

Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Antidepressants: FDA warns of paediatric suicide risk

By  

Inpharma, Vol. 1, Iss. 1412, 2003-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite